# Singular Genomics Systems Inc. (OMIC)

Source: https://www.quantisnow.com/company/OMIC
Generated: 2026-11-16T21:10:31.002Z

- Ticker: OMIC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Laboratory Analytical Instruments
- IPO year: 2021
- Website: singulargenomics.com

## About

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.

## Latest OMIC news and filings

- 2025-02-28 01:54 UTC [SEC Form 4] [Large owner Tang Kevin returned 372,000 shares to the company (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-tang-kevin-returned-372000-shares-to-the-company-5915894)
- 2025-02-27 18:42 UTC [SEC Form 8-K] [Singular Genomics Systems Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Material Modification to Rights of Security Holders, Changes in Control of Registrant](https://www.quantisnow.com/insight/singular-genomics-systems-inc-filed-sec-form-8-k-completion-of-5914024)
- 2025-02-26 02:18 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-singular-genomics-systems-5909873)
- 2025-02-26 01:12 UTC [SEC Form 4] [Chief Executive Officer Spaventa Andrew returned 143,310 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-spaventa-andrew-returned-143310-shares-to-the-5909724)
- 2025-02-26 01:11 UTC [SEC Form 4] [Chief Financial Officer Meeter Dalen returned 9,502 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-meeter-dalen-returned-9502-shares-to-the-5909720)
- 2025-02-26 01:11 UTC [SEC Form 4] [Chief Scientific Officer Glezer Eli N. returned 155,583 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-scientific-officer-glezer-eli-n-returned-155583-shares-to-5909719)
- 2025-02-26 01:10 UTC [SEC Form 4] [Chief Operating Officer Ghai Jyotsna returned 3,283 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-ghai-jyotsna-returned-3283-shares-to-the-5909717)
- 2025-02-26 01:08 UTC [SEC Form 4] [SEC Form 4 filed by Director Ryan Jason](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-ryan-jason-5909709)
- 2025-02-26 01:07 UTC [SEC Form 4] [Director Pellini Michael J returned 351,222 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-pellini-michael-j-returned-351222-shares-to-the-company-5909700)
- 2025-02-26 01:06 UTC [SEC Form 4] [SEC Form 4 filed by Director Mardis Elaine R](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-mardis-elaine-r-5909698)
- 2025-02-26 01:05 UTC [SEC Form 4] [Director Kamdar Kim P. returned 3,793,985 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-kamdar-kim-p-returned-3793985-shares-to-the-company-5909695)
- 2025-02-26 01:04 UTC [SEC Form 4] [SEC Form 4 filed by Director Eisenberg Marcia](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-eisenberg-marcia-5909694)
- 2025-02-26 01:01 UTC [SEC Form 4] [Director Barker David L returned 1,060,000 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-barker-david-l-returned-1060000-shares-to-the-company-5909686)
- 2025-02-24 13:00 UTC [Singular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBT](https://www.quantisnow.com/insight/singular-highlights-key-g4x-launch-milestones-and-showcases-groundbreaking-3d-5904416)
- 2025-02-24 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-singular-genomics-systems-inc-5904122)
- 2025-02-21 14:56 UTC [Public Offering] [Singular Genomics Announces Closing of Acquisition by Deerfield Management](https://www.quantisnow.com/insight/singular-genomics-announces-closing-of-acquisition-by-deerfield-management-5902245)
- 2025-02-21 14:11 UTC [SEC Form 25-NSE filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-singular-genomics-systems-inc-5902211)
- 2025-02-21 12:59 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-singular-genomics-systems-inc-5902052)
- 2025-02-21 12:56 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-singular-genomics-systems-inc-5902051)
- 2025-02-21 12:54 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-singular-genomics-systems-inc-5902050)
- 2025-02-21 12:51 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-singular-genomics-systems-inc-5902048)
- 2025-02-21 12:48 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-singular-genomics-systems-inc-5902047)
- 2025-02-21 12:45 UTC [SEC Form POS AM filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-singular-genomics-systems-inc-5902046)
- 2025-02-19 22:26 UTC [SEC Form 8-K] [SEC Form 8-K filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-singular-genomics-systems-inc-5897806)
- 2025-02-14 22:00 UTC [SEC Form 4] [Chief Executive Officer Spaventa Andrew converted options into 1,907 shares, sold $15,912 worth of shares (800 units at $19.89), gifted 1,107 shares and received a gift of 1,107 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-spaventa-andrew-converted-options-into-1907-shares-5891531)
- 2025-02-13 22:10 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-singular-genomics-systems-inc-5888267)
- 2025-02-13 22:08 UTC [SEC Form 8-K] [SEC Form 8-K filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-singular-genomics-systems-inc-5888250)
- 2025-02-11 23:01 UTC [SEC Form 4] [Chief Financial Officer Meeter Dalen converted options into 500 shares, increasing direct ownership by 6% to 9,502 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-meeter-dalen-converted-options-into-500-shares-5882805)
- 2025-02-11 22:59 UTC [SEC Form 4] [Chief Scientific Officer Glezer Eli N. converted options into 500 shares, increasing direct ownership by 0.32% to 155,583 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-scientific-officer-glezer-eli-n-converted-options-into-500-5882801)
- 2025-02-11 22:57 UTC [SEC Form 4] [Chief Operating Officer Ghai Jyotsna converted options into 250 shares, increasing direct ownership by 8% to 3,283 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-ghai-jyotsna-converted-options-into-250-shares-5882784)
- 2025-01-16 19:52 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-singular-genomics-systems-5848313)
- 2025-01-15 00:26 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-singular-genomics-systems-inc-5846228)
- 2025-01-06 23:48 UTC [SEC Form 4] [Chief Operating Officer Ghai Jyotsna converted options into 417 shares, increasing direct ownership by 16% to 3,033 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-ghai-jyotsna-converted-options-into-417-shares-5836129)
- 2024-12-31 22:23 UTC [SEC Form PREM14A filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-prem14a-filed-by-singular-genomics-systems-inc-5828197)
- 2024-12-27 01:55 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-singular-genomics-systems-5825552)
- 2024-12-23 21:58 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Singular Genomics Systems Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-singular-genomics-systems-inc-5824145)
- 2024-12-23 21:56 UTC [SEC Form 8-K] [Singular Genomics Systems Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/singular-genomics-systems-inc-filed-sec-form-8-k-other-events-5824137)
- 2024-12-23 13:30 UTC [Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share](https://www.quantisnow.com/insight/singular-genomics-enters-into-agreement-to-be-acquired-by-deerfield-5823281)
- 2024-12-17 22:36 UTC [SEC Form 4] [Chief Executive Officer Spaventa Andrew converted options into 486 shares, sold $3,629 worth of shares (180 units at $20.16), gifted 306 shares and received a gift of 306 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-spaventa-andrew-converted-options-into-486-shares-5817496)
- 2024-12-17 22:34 UTC [SEC Form 4] [Chief Financial Officer Meeter Dalen converted options into 209 shares, increasing direct ownership by 2% to 9,002 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-meeter-dalen-converted-options-into-209-shares-5817490)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/OMIC
- Earnings history: https://www.quantisnow.com/earnings/OMIC
- Dividend history: https://www.quantisnow.com/dividends/OMIC
- Insider transactions: https://www.quantisnow.com/insiders/OMIC
- Options chain: https://www.quantisnow.com/options/OMIC
- SEC 8-K filings only: https://www.quantisnow.com/company/OMIC/8-k
- RSS and alerts for OMIC: https://www.quantisnow.com/docs/rss-feeds.md
